Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials

Background Isolated systolic hypertension (ISH) in middle-aged and elderly is associated with high cardiovascular risk, but no randomised controlled trial has assessed the effect of antihypertensive treatment in ISH using today’s definition, i.e. systolic blood pressure (SBP) ≥140 mmHg and diastolic...

Full description

Bibliographic Details
Main Authors: Mattias Brunström, Bo Carlberg, Sverre E. Kjeldsen
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Blood Pressure
Subjects:
Online Access:http://dx.doi.org/10.1080/08037051.2023.2226757
_version_ 1827808985467584512
author Mattias Brunström
Bo Carlberg
Sverre E. Kjeldsen
author_facet Mattias Brunström
Bo Carlberg
Sverre E. Kjeldsen
author_sort Mattias Brunström
collection DOAJ
description Background Isolated systolic hypertension (ISH) in middle-aged and elderly is associated with high cardiovascular risk, but no randomised controlled trial has assessed the effect of antihypertensive treatment in ISH using today’s definition, i.e. systolic blood pressure (SBP) ≥140 mmHg and diastolic blood pressure (DBP) <90 mmHg. Methods A systematic review and meta-analysis of randomised controlled trials was performed. Studies with ≥1000 patient-years of follow-up, comparing more intensive versus less intensive BP targets, or active drug versus placebo, were included if the mean baseline SBP was ≥140 mmHg and the mean baseline DBP was <90 mmHg. The primary outcome was major adverse cardiovascular events (MACE). Relative risks from each trial were pooled in random-effects meta-analyses, stratified by baseline and attained SBP level. Results Twenty-four trials, including 113,105 participants (mean age 67 years; mean blood pressure 149/83 mmHg) were included in the analysis. Overall, treatment reduced the risk of MACE by 9% (relative risk 0.91, 95% confidence interval 0.88–0.93). Treatment was more effective if baseline SBP was ≥160 mmHg (RR 0.77, 95% CIs 0.70–0.86) compared to 140–159 mmHg (RR 0.92, 95% CIs 0.89–0.95; p = 0.002 for interaction), but provided equal additional benefit across all attained SBP levels (RR 0.80, 95% CIs 0.70–0.92 for <130 mmHg, RR 0.92, 95% CIs 0.89–0.96 for 130–139 mmHg, and RR 0.87, 95% CIs 0.82–0.93 for ≥140 mmHg; p = 0.070 for interaction). Conclusions These findings support antihypertensive treatment of isolated systolic hypertension, regardless of baseline SBP, to target SBP <140 mmHg and even <130 mmHg if well tolerated.
first_indexed 2024-03-11T22:35:36Z
format Article
id doaj.art-1e922ce07d9140b497426516abd734c8
institution Directory Open Access Journal
issn 0803-7051
1651-1999
language English
last_indexed 2024-03-11T22:35:36Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Blood Pressure
spelling doaj.art-1e922ce07d9140b497426516abd734c82023-09-22T13:57:07ZengTaylor & Francis GroupBlood Pressure0803-70511651-19992023-12-0132110.1080/08037051.2023.22267572226757Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trialsMattias Brunström0Bo Carlberg1Sverre E. Kjeldsen2Department of Public Health and Clinical Medicine, Umeå UniversityDepartment of Public Health and Clinical Medicine, Umeå UniversityDepartment of Cardiology, Institute for Clinical Medicine, Ullevaal Hospital, University of OsloBackground Isolated systolic hypertension (ISH) in middle-aged and elderly is associated with high cardiovascular risk, but no randomised controlled trial has assessed the effect of antihypertensive treatment in ISH using today’s definition, i.e. systolic blood pressure (SBP) ≥140 mmHg and diastolic blood pressure (DBP) <90 mmHg. Methods A systematic review and meta-analysis of randomised controlled trials was performed. Studies with ≥1000 patient-years of follow-up, comparing more intensive versus less intensive BP targets, or active drug versus placebo, were included if the mean baseline SBP was ≥140 mmHg and the mean baseline DBP was <90 mmHg. The primary outcome was major adverse cardiovascular events (MACE). Relative risks from each trial were pooled in random-effects meta-analyses, stratified by baseline and attained SBP level. Results Twenty-four trials, including 113,105 participants (mean age 67 years; mean blood pressure 149/83 mmHg) were included in the analysis. Overall, treatment reduced the risk of MACE by 9% (relative risk 0.91, 95% confidence interval 0.88–0.93). Treatment was more effective if baseline SBP was ≥160 mmHg (RR 0.77, 95% CIs 0.70–0.86) compared to 140–159 mmHg (RR 0.92, 95% CIs 0.89–0.95; p = 0.002 for interaction), but provided equal additional benefit across all attained SBP levels (RR 0.80, 95% CIs 0.70–0.92 for <130 mmHg, RR 0.92, 95% CIs 0.89–0.96 for 130–139 mmHg, and RR 0.87, 95% CIs 0.82–0.93 for ≥140 mmHg; p = 0.070 for interaction). Conclusions These findings support antihypertensive treatment of isolated systolic hypertension, regardless of baseline SBP, to target SBP <140 mmHg and even <130 mmHg if well tolerated.http://dx.doi.org/10.1080/08037051.2023.2226757isolated systolic hypertensionantihypertensive treatmentblood pressure targetblood pressure goalelderly
spellingShingle Mattias Brunström
Bo Carlberg
Sverre E. Kjeldsen
Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials
Blood Pressure
isolated systolic hypertension
antihypertensive treatment
blood pressure target
blood pressure goal
elderly
title Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials
title_full Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials
title_fullStr Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials
title_full_unstemmed Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials
title_short Effect of antihypertensive treatment in isolated systolic hypertension (ISH) – systematic review and meta-analysis of randomised controlled trials
title_sort effect of antihypertensive treatment in isolated systolic hypertension ish systematic review and meta analysis of randomised controlled trials
topic isolated systolic hypertension
antihypertensive treatment
blood pressure target
blood pressure goal
elderly
url http://dx.doi.org/10.1080/08037051.2023.2226757
work_keys_str_mv AT mattiasbrunstrom effectofantihypertensivetreatmentinisolatedsystolichypertensionishsystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT bocarlberg effectofantihypertensivetreatmentinisolatedsystolichypertensionishsystematicreviewandmetaanalysisofrandomisedcontrolledtrials
AT sverreekjeldsen effectofantihypertensivetreatmentinisolatedsystolichypertensionishsystematicreviewandmetaanalysisofrandomisedcontrolledtrials